Method for treating neurocognitive disorders

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514171, 514264, 514297, 546105, 546200, 546201, A61K 31445

Patent

active

054341701

ABSTRACT:
A method for treating a central nervous system or peripheral nervous system cholinergic deficit state in a mammalian organism in need of such treatment, said method comprising administering to said mammal an amount of thalidomide effective in the treatment of a cholinergic deficit state and for a time sufficient to achieve a suitable blood level to treat said cholinergic deficit state.

REFERENCES:
patent: 2830991 (1958-04-01), Keller et al.
patent: 4816456 (1989-03-01), Summers
patent: 4839364 (1989-06-01), Shutske et al.
patent: 5210087 (1993-05-01), Shutske et al.
patent: 5318967 (1994-06-01), Bruderer et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for treating neurocognitive disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating neurocognitive disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating neurocognitive disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2419116

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.